Baricitinib Provides Significant Improvements in Quality of Life and Functioning in Adults with Moderate-to-Severe Atopic Dermatitis with Baseline Body Surface Area ≤ 40% and Severe Itch

Abstract Introduction Patients with moderate-to-severe atopic dermatitis (AD), a body surface area (BSA) of ≤ 40%, and an itch numerical rating scale (NRS) score of ≥ 7 (“BARI itch dominant”) have been characterized as an important group to consider for the oral janus kinase (JAK) 1/2 inhibitor bari...

Полное описание

Библиографические подробности

Главные авторы:	Matthias Augustin, Maddalena Napolitano, Rosa Izu-Belloso, C. Elise Kleyn, Silvia Sabatino, Susanne Grond, Joaquin R. Otero-Asman, Chunyuan Liu, Ziad Reguiai, Toshifumi Nomura
Формат:	Artigo
Язык:	Inglês
Опубликовано:	Adis, Springer Healthcare 2025-01-01
Серии:	Dermatology and Therapy
Предметы:	Atopic dermatitis Health-related life quality index Severe itch Dermatology Life Quality Index
Online-ссылка:	https://doi.org/10.1007/s13555-024-01330-w
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!